Publications by authors named "Colin Quinn"

Claim this Profile
C
Cumulative incidence of motor and cognitive features in the amyotrophic lateral sclerosis-frontotemporal degeneration spectrum.
Barbara E Spencer, Sharon X Xie, Daniel T Ohm, Lauren Elman, Colin C Quinn

Brain Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy.
Marianela Schiava, Yolande Parkhurst, Matthew Henderson, Tuomo Polvikoski, Manouela V Valtcheva, Colin C Quinn

Neurol Genet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic associations with clinical and neuropathological trait heterogeneity across TDP-43 proteinopathies.
Barbara E Spencer, David J Irwin, Vivianna M Van Deerlin, EunRan Suh, Edward B Lee, Colin C Quinn

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative Incidence of Motor and Cognitive Features in the ALS-FTD Spectrum.
Barbara E Spencer, Sharon X Xie, Daniel T Ohm, Lauren Elman, Colin C Quinn

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Extended Cardiac Rhythm Monitoring Detects More Arrhythmias in Myotonic Dystrophy Patients.
Melissa A Austin, Gregory E Supple, Samuel Carrell, Colin Quinn, Lauren Elman

JACC Clin Electrophysiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial Fibrillation and Flutter in a Contemporary Cohort of Patients With Myotonic Muscular Dystrophy.
Melissa A Austin, Gregory E Supple, Samuel Carrell, Colin Quinn, Lauren Elman

JACC Clin Electrophysiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Advancing Risk Assessment in Myotonic Muscular Dystrophy Through Translational Research and Personalized Medicine.
Melissa A Austin, Gregory E Supple, Samuel Carrell, Colin Quinn, Lauren Elman

JACC Clin Electrophysiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALS Motor Observational Telemedicine Objective Rasch-Built Assessment: A Quantitative Scale for the Era of Teleneurology.
Christina N Fournier, Mark Levine, Karon Simmons, Rocío Carolina García-Santibáñez, Anne Rowland, Colin C Quinn

Neurol Clin Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms.
Colin H Quinn, Janet R Julson, Michael H Erwin, Hooper R Markert, Larua V Bownes

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of .
Swatika Butey, Morgan L Brown, Janet R Julson, Raoud Marayati, Venkatram R Atigadda, Colin H Quinn

Int J Mol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Amyotrophic Lateral Sclerosis Multidisciplinary Clinic: Broke but Not Broken.
Christina N Fournier, Colin C Quinn

Neurology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Iterative Shifting Disaggregation Algorithm for Multi-Source, Irregularly Sampled, and Overlapped Time Series.
Colin O Quinn, Ronald H Brown, George F Corliss, Richard J Povinelli

Sensors (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastoma.
Nazia Nazam, Michael H Erwin, Janet R Julson, Colin H Quinn, Andee M Beierle

J Biol Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel PP2A-Activating Compounds in Neuroblastoma.
Nazia Nazam, Laura V Bownes, Janet R Julson, Colin H Quinn, Michael H Erwin

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Peer-Led Learning Groups on First-Year Medical Students.
Sam E Gary, Samuel F Chang, Colin H Quinn, James Baños, Brook Hubner

Med Sci Educ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors.
Colin H Quinn, Andee M Beierle, Adele P Williams, Raoud Marayati, Laura V Bownes

Transl Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma.
Colin H Quinn, Janet R Julson, Hooper R Markert, Nazia Nazam, Swatika Butey

Cancer Immunol Immunother· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive reserve in ALS: the role of occupational skills and requirements.
Emma Rhodes, Sebleh Alfa, Hannah A Jin, Lauren Massimo, Lauren Elman, Colin Quinn

Amyotroph Lateral Scler Frontotemporal Degener· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Clinical Infrastructure for the Delivery of Intrathecal and Genetic Therapies: A Qalsody (Tofersen) Model for Patients With -ALS.
Jennifer Morganroth, Tanya M Bardakjian, Laynie Dratch, Colin C Quinn, Lauren B Elman

Neurol Clin Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.
Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins, Colin H Quinn, Joelle Saad

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIM Kinase Inhibition Sensitizes Neuroblastoma to Doxorubicin.
Janet R Julson, Colin H Quinn, Nazia Nazam, Laura V Bownes, Jerry E Stewart

J Pediatr Surg· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single ALS center experience with clinical use of sodium phenylbutyrate-taurursodiol.
Colin Quinn, Michael Baer, Defne A Amado, Mary Kelley, Lauren Elman

Muscle Nerve· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Michael Benatar, Thomas Hansen, Dror Rom, Marie A Geist, Thomas Blaettler, Colin Quinn

Lancet Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in Genetic Testing for Neurologic Disorders.
Aaron Baldwin, Juliette Copeland, Meron Azage, Laynie Dratch, Kelsey Johnson, Colin C Quinn

Neurology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caring for young adult men with inflammatory bowel disease: Clinician and patient perspectives.
Amy K Bugwadia, Sydney Reed, Adam Finkelstein, Peter Park, Colin Quinn

Health Care Transit· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis